3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
13
Zollinger-Ellison Syndrome
2
Vipoma
2
Somatostatinoma
2
Pheochromocytoma
2
Gastro-enteropancreatic neuroendocrine tumor
2
Carcinoma, Neuroendocrine
2
Carcinoma, Medullary
2
Carcinoid Tumor
2
Small Cell Lung Carcinoma
1
Pancreatic Neoplasms
1
Non functioning pancreatic endocrine tumor
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 2b
1
Multiple Endocrine Neoplasia Type 2a
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
1
Lung Neoplasms
1
Insulinoma
1
Glucagonoma
1
Gastroenteropancreatic Neuroendocrine Tumors
1
Gastrinoma
1
Frailty
1
Extrapancreatic Neuroendocrine Tumor
1
Carcinoma, Merkel Cell
1
Adrenal Cortex Neoplasms
1
Interventions
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Frailty
×
Temozolomide
×
NET
×
Clear all
NCT05554003
2024-11-18
MeTe
European Institute of Oncology
Phase 2
Recruiting
46 enrolled